Bethesda, MD, United States of America

Gyorgy Petrovics

USPTO Granted Patents = 12 

 

 

Average Co-Inventor Count = 2.8

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2013-2024

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Gyorgy Petrovics: Innovator in Prostate Cancer Research

Introduction

Gyorgy Petrovics is a prominent inventor based in Bethesda, MD, known for his significant contributions to the field of prostate cancer research. With a total of 12 patents to his name, Petrovics has made strides in understanding the genetic profiles associated with prostate cancer, particularly in differentiating between various ethnic groups.

Latest Patents

Among his latest patents, Petrovics has developed gene expression profiles that are associated with prostate cancer. These profiles not only differentiate between subjects of African and Caucasian descent but also provide insights into commonalities between these groups. His work includes methods for diagnosing and prognosing prostate cancer, utilizing gene expression levels to identify subjects who may benefit from specific treatments. Additionally, he has focused on the ERG gene and its role in prostate cancer, offering therapeutic compositions and methods for detecting and treating this disease.

Career Highlights

Throughout his career, Gyorgy Petrovics has worked with notable organizations, including the Henry M. Jackson Foundation for the Advancement of Military Medicine and Genomatix Software GmbH. His research has been pivotal in advancing the understanding of prostate cancer and developing innovative diagnostic tools.

Collaborations

Petrovics has collaborated with esteemed colleagues such as Shiv Srivastava and Albert Dobi, contributing to a rich exchange of ideas and research in the field of cancer genetics.

Conclusion

Gyorgy Petrovics stands out as a key figure in prostate cancer research, with a focus on genetic profiling and innovative treatment methods. His contributions continue to impact the medical community and improve patient outcomes in prostate cancer treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…